{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:05:53Z","timestamp":1794056753172,"version":"4.8.0"},"reference-count":57,"publisher":"American Society of Hematology","issue":"20","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,5,18]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Combination of Ig\/TCR and BCR-ABL1 genomic approach for MRD monitoring in childhood ALL reveals patients with CML-like disease. Monitoring ALL using BCR-ABL1 genomic breakpoint is feasible and enables the most specific and sensitive MRD quantification.<\/jats:p>","DOI":"10.1182\/blood-2016-11-749978","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T21:04:35Z","timestamp":1490216675000},"page":"2771-2781","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":132,"title":["Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology"],"prefix":"10.1182","volume":"129","author":[{"given":"Lenka","family":"Hovorkova","sequence":"first","affiliation":[{"name":"Childhood Leukemia Investigation Prague (CLIP) and"},{"name":"Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marketa","family":"Zaliova","sequence":"additional","affiliation":[{"name":"Childhood Leukemia Investigation Prague (CLIP) and"},{"name":"Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;"},{"name":"University Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola C.","family":"Venn","sequence":"additional","affiliation":[{"name":"Children\u2019s Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Bleckmann","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Trkova","sequence":"additional","affiliation":[{"name":"Gennet, Center for Fetal Medicine and Reproductive Genetics, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliska","family":"Potuckova","sequence":"additional","affiliation":[{"name":"Childhood Leukemia Investigation Prague (CLIP) and"},{"name":"Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Vaskova","sequence":"additional","affiliation":[{"name":"Childhood Leukemia Investigation Prague (CLIP) and"},{"name":"Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Linhartova","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Blood Transfusion, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Machova Polakova","sequence":"additional","affiliation":[{"name":"Institute of Hematology and Blood Transfusion, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Fronkova","sequence":"additional","affiliation":[{"name":"Childhood Leukemia Investigation Prague (CLIP) and"},{"name":"Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Muskovic","sequence":"additional","affiliation":[{"name":"Children\u2019s Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie E.","family":"Giles","sequence":"additional","affiliation":[{"name":"Children\u2019s Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Shaw","sequence":"additional","affiliation":[{"name":"Blood and Marrow Transplant Services, Children\u2019s Hospital at Westmead, Sydney, NSW, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Cario","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Sutton","sequence":"additional","affiliation":[{"name":"Children\u2019s Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Sydney, NSW, Australia;"},{"name":"School of Women\u2019s and Children\u2019s Health, University of New South Wales, Sydney, NSW, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Stary","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;"},{"name":"University Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Trka","sequence":"additional","affiliation":[{"name":"Childhood Leukemia Investigation Prague (CLIP) and"},{"name":"Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;"},{"name":"University Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Zuna","sequence":"additional","affiliation":[{"name":"Childhood Leukemia Investigation Prague (CLIP) and"},{"name":"Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic;"},{"name":"University Hospital Motol, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"8","key":"2019111903503327000_B1","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Quint\u00e1s-Cardama","year":"2009","journal-title":"Blood"},{"issue":"6","key":"2019111903503327000_B2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/sj.leu.2402963","article-title":"Patterns of BCR\/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR\/ABL+ leukemias: incidence and underlying genetic abnormalities","volume":"17","author":"Primo","year":"2003","journal-title":"Leukemia"},{"issue":"9","key":"2019111903503327000_B3","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(12)70377-7","article-title":"Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study","volume":"13","author":"Biondi","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"2019111903503327000_B4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1365-2141.2002.03838.x","article-title":"Prospective molecular monitoring of BCR\/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response","volume":"119","author":"Cazzaniga","year":"2002","journal-title":"Br J Haematol"},{"issue":"26","key":"2019111903503327000_B5","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/blood-2015-02-580043","article-title":"Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine","volume":"125","author":"Hunger","year":"2015","journal-title":"Blood"},{"key":"2019111903503327000_B6","article-title":"Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995","author":"Ries","year":"1999"},{"issue":"14","key":"2019111903503327000_B7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"342","author":"Aric\u00f2","year":"2000","journal-title":"N Engl J Med"},{"issue":"31","key":"2019111903503327000_B8","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children\u2019s oncology group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019111903503327000_B9","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/leu.2014.30","article-title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children\u2019s Oncology Group study AALL0031","volume":"28","author":"Schultz","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"2019111903503327000_B10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11899-012-0113-6","article-title":"Management of chronic myeloid leukemia in childhood","volume":"7","author":"Suttorp","year":"2012","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"2019111903503327000_B11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/bjh.12977","article-title":"Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years","volume":"167","author":"de la Fuente","year":"2014","journal-title":"Br J Haematol"},{"issue":"4","key":"2019111903503327000_B12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2015-06-648667","article-title":"Pediatric chronic myeloid leukemia is a unique disease that requires a different approach","volume":"127","author":"Hijiya","year":"2016","journal-title":"Blood"},{"issue":"8","key":"2019111903503327000_B13","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1182\/blood-2011-10-380774","article-title":"How I treat childhood CML","volume":"119","author":"Andolina","year":"2012","journal-title":"Blood"},{"issue":"suppl 2","key":"2019111903503327000_B14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00277-015-2324-0","article-title":"Management of chronic myeloid leukemia in blast crisis","volume":"94","author":"Sau\u00dfele","year":"2015","journal-title":"Ann Hematol"},{"issue":"5","key":"2019111903503327000_B15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/leu.2008.386","article-title":"Quantification of fusion transcript reveals a subgroup with distinct biological properties and predicts relapse in BCR\/ABL-positive ALL: implications for residual disease monitoring","volume":"23","author":"Zaliova","year":"2009","journal-title":"Leukemia"},{"issue":"16","key":"2019111903503327000_B16","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1182\/blood-2009-10-248146","article-title":"Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study","volume":"115","author":"Conter","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111903503327000_B17","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jmoldx.2015.09.005","article-title":"Next-generation sequencing-assisted DNA-based digital PCR for a personalized approach to the detection and quantification of residual disease in chronic myeloid leukemia patients","volume":"18","author":"Alikian","year":"2016","journal-title":"J Mol Diagn"},{"issue":"2","key":"2019111903503327000_B18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jmoldx.2014.10.002","article-title":"A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemia","volume":"17","author":"Bartley","year":"2015","journal-title":"J Mol Diagn"},{"issue":"2","key":"2019111903503327000_B19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2141.2009.08071.x","article-title":"Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemia","volume":"149","author":"Bartley","year":"2010","journal-title":"Br J Haematol"},{"issue":"6, pt 1","key":"2019111903503327000_B20","doi-asserted-by":"crossref","first-page":"e222","DOI":"10.1111\/j.1751-553X.2010.01236.x","article-title":"Sensitive detection and quantification of minimal residual disease in chronic myeloid leukaemia using nested quantitative PCR for BCR-ABL DNA","volume":"32","author":"Bartley","year":"2010","journal-title":"Int J Lab Hematol"},{"issue":"11","key":"2019111903503327000_B21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.dnarep.2011.08.010","article-title":"Fine structure of translocation breakpoints within the major breakpoint region in BCR-ABL1-positive leukemias","volume":"10","author":"Burmeister","year":"2011","journal-title":"DNA Repair (Amst)"},{"issue":"11","key":"2019111903503327000_B22","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/gcc.21989","article-title":"Genomic BCR-ABL1 breakpoints in pediatric chronic myeloid leukemia","volume":"51","author":"Krumbholz","year":"2012","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"2019111903503327000_B23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/gcc.20568","article-title":"Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia","volume":"47","author":"Mattarucchi","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"2019111903503327000_B24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.18632\/oncoscience.65","article-title":"Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in chronic myeloid leukemia","volume":"1","author":"Pagani","year":"2014","journal-title":"Oncoscience"},{"issue":"10","key":"2019111903503327000_B25","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/leu.2010.185","article-title":"Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCR","volume":"24","author":"Ross","year":"2010","journal-title":"Leukemia"},{"issue":"10","key":"2019111903503327000_B26","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1038\/leu.2013.116","article-title":"Distribution of genomic breakpoints in chronic myeloid leukemia: analysis of 308 patients","volume":"27","author":"Ross","year":"2013","journal-title":"Leukemia"},{"issue":"10","key":"2019111903503327000_B27","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/leu.2010.174","article-title":"Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation","volume":"24","author":"Score","year":"2010","journal-title":"Leukemia"},{"issue":"9","key":"2019111903503327000_B28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/gm191","article-title":"Detection of DNA fusion junctions for BCR-ABL translocations by anchored chromPET","volume":"2","author":"Shibata","year":"2010","journal-title":"Genome Med"},{"issue":"8","key":"2019111903503327000_B29","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/blood-2009-11-255109","article-title":"In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib","volume":"116","author":"Sobrinho-Sim\u00f5es","year":"2010","journal-title":"Blood"},{"issue":"8","key":"2019111903503327000_B30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.cancergen.2011.07.007","article-title":"Identification of chromosomal breakpoints of cancer-specific translocations by rolling circle amplification and long-distance inverse PCR","volume":"204","author":"Thorsen","year":"2011","journal-title":"Cancer Genet"},{"issue":"12","key":"2019111903503327000_B31","first-page":"4146","article-title":"Long-template DNA polymerase chain reaction for the detection of the bcr\/abl translocation in patients with chronic myelogenous leukemia","volume":"5","author":"Waller","year":"1999","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2019111903503327000_B32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2141.1995.tb03392.x","article-title":"Characterization of genomic BCR-ABL breakpoints in chronic myeloid leukaemia by PCR","volume":"90","author":"Zhang","year":"1995","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111903503327000_B33","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1182\/blood.V87.6.2588.bloodjournal8762588","article-title":"Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation","volume":"87","author":"Zhang","year":"1996","journal-title":"Blood"},{"issue":"11","key":"2019111903503327000_B34","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood-2013-06-509794","article-title":"IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL","volume":"123","author":"van der Veer","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2019111903503327000_B35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.leu.2401245","article-title":"Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia","volume":"13","author":"Pongers-Willemse","year":"1999","journal-title":"Leukemia"},{"issue":"12","key":"2019111903503327000_B36","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/sj.leu.2403136","article-title":"Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program","volume":"17","author":"Beillard","year":"2003","journal-title":"Leukemia"},{"issue":"1","key":"2019111903503327000_B37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/cncr.11043","article-title":"Slower molecular response to treatment predicts poor outcome in patients with TEL\/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study","volume":"97","author":"Mad\u017eo","year":"2003","journal-title":"Cancer"},{"key":"2019111903503327000_B38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-015-0363-8","article-title":"Characterization of 46 patient-specific BCR-ABL1 fusions and detection of SNPs upstream and downstream the breakpoints in chronic myeloid leukemia using next generation sequencing","volume":"14","author":"Linhartova","year":"2015","journal-title":"Mol Cancer"},{"issue":"3","key":"2019111903503327000_B39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol"},{"issue":"D1","key":"2019111903503327000_B40","doi-asserted-by":"crossref","first-page":"D710","DOI":"10.1093\/nar\/gkv1157","article-title":"Ensembl 2016","volume":"44","author":"Yates","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2019111903503327000_B41","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1101\/gr.229202","article-title":"BLAT--the BLAST-like alignment tool","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res"},{"issue":"6","key":"2019111903503327000_B42","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/leu.2011.348","article-title":"Highly sensitive MRD tests for ALL based on the IKZF1 \u03943-6 microdeletion","volume":"26","author":"Venn","year":"2012","journal-title":"Leukemia"},{"issue":"4","key":"2019111903503327000_B43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3324\/haematol.2012.073965","article-title":"Breakpoint-specific multiplex polymerase chain reaction allows the detection of IKZF1 intragenic deletions and minimal residual disease monitoring in B-cell precursor acute lymphoblastic leukemia","volume":"98","author":"Caye","year":"2013","journal-title":"Haematologica"},{"issue":"12","key":"2019111903503327000_B44","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"issue":"8","key":"2019111903503327000_B45","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1182\/blood.V98.8.2456","article-title":"Basic helix-loop-helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells","volume":"98","author":"Langerak","year":"2001","journal-title":"Blood"},{"issue":"5","key":"2019111903503327000_B46","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/sj.leu.2402475","article-title":"Immunoglobulin kappa deleting element rearrangements in precursor-B acute lymphoblastic leukemia are stable targets for detection of minimal residual disease by real-time quantitative PCR","volume":"16","author":"van der Velden","year":"2002","journal-title":"Leukemia"},{"issue":"7","key":"2019111903503327000_B47","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/sj.leu.2402515","article-title":"T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis","volume":"16","author":"van der Velden","year":"2002","journal-title":"Leukemia"},{"issue":"8","key":"2019111903503327000_B48","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.leu.2401801","article-title":"Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia","volume":"14","author":"Verhagen","year":"2000","journal-title":"Leukemia"},{"issue":"4","key":"2019111903503327000_B49","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.leu.2404586","article-title":"Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data","volume":"21","author":"van der Velden","year":"2007","journal-title":"Leukemia"},{"issue":"12","key":"2019111903503327000_B50","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/sj.leu.2403135","article-title":"Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program","volume":"17","author":"Gabert","year":"2003","journal-title":"Leukemia"},{"issue":"12","key":"2019111903503327000_B51","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1093\/oxfordjournals.humrep.a135898","article-title":"The use of fluorescent in-situ hybridization (FISH) for the analysis of in-vitro fertilization embryos: a diagnostic tool for the infertile couple","volume":"10","author":"Harper","year":"1995","journal-title":"Hum Reprod"},{"issue":"6","key":"2019111903503327000_B52","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/leu.2010.63","article-title":"Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia","volume":"24","author":"Virely","year":"2010","journal-title":"Leukemia"},{"issue":"7191","key":"2019111903503327000_B53","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"issue":"9","key":"2019111903503327000_B54","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3324\/haematol.2016.144345","article-title":"Characterization of leukemias with ETV6-ABL1 fusion","volume":"101","author":"Zaliova","year":"2016","journal-title":"Haematologica"},{"issue":"1","key":"2019111903503327000_B55","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/gcc.20622","article-title":"Covert preleukemia driven by MLL gene fusion","volume":"48","author":"Zuna","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"issue":"18","key":"2019111903503327000_B56","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood-2016-07-725861","article-title":"Distinct bilineal leukemia immunophenotypes are not genetically determined","volume":"128","author":"Kotrova","year":"2016","journal-title":"Blood"},{"issue":"13","key":"2019111903503327000_B57","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1073\/pnas.1413383112","article-title":"Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages","volume":"112","author":"McClellan","year":"2015","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/20\/2771\/1400839\/blood749978.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/20\/2771\/1400839\/blood749978.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T03:51:05Z","timestamp":1574135465000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/20\/2771\/36116\/Monitoring-of-childhood-ALL-using-BCRABL1-genomic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":57,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017,5,18]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-11-749978","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}